Android app on Google Play

Unusual 11 Midday Movers 02/13: (GNOM) (GEVO) (NEP) Higher; (CHTP) (CRD-A) (NTE) Lower

February 13, 2012 2:47 PM EST Send to a Friend
Complete Genomics Inc. (Nasdaq: GNOM) 46.8% HIGHER; announced today that it has been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing. Mayo Clinic researchers will now be able to employ Complete Genomics' sequencing service for some of its large-scale whole genome sequencing projects.

Chelsea Therapeutics International, Ltd. (Nasdaq: CHTP) 36% LOWER; announced that during a presentation at the 14th Annual BIO CEO and Investor Conference president and CEO, Dr. Simon Pedder, plans to provide an update regarding the company's New Drug Application (NDA) forT NORHERA™ (droxidopa), an overview of key issues identified in the FDA briefing document received by the company and anticipated discussion points for the upcoming Cardiovascular and Renal Drugs Advisory Committee (CRDAC) meeting scheduled for February 23rd. Click here for the full report.

Gevo Inc. (Nasdaq: GEVO) 20% HIGHER; shares are trading up today on slightly heavier volumes after breaking through technical levels at $9 and $9.30.

Crawford & Co. (NYSE: CRD-A) 15.4% LOWER; reported Q4 EPS of $0.03, versus $0.33 reported last year. Revenue for the quarter came in at $265.6 million, versus $301.5 million reported last year. The company sees FY2012 EPS of $0.52-$0.62 and FY2012 revenue of $990-$1030 million. Crawford also declared its regular $0.03 quarterly dividend.

China North East Petroleum Holding Ltd. (AMEX: NEP) 14.5% HIGHER; shares continuing to breakout after crossing the 200-day SMA at a price around $2.33 on Friday afternoon. Shares closed Friday's session up about 14 percent.

Simulations Plus, Inc. (NASDAQ: SLP) 13.9% HIGHER; declared a quarterly dividend of $0.05 per share, or $0.2 annualized.

Nam Tai Electronics, Inc. (NYSE: NTE) 13.2% LOWER; reported Q4 EPS of ($0.01), versus $0.12 reported last year. Revenue for the quarter came in at $145.3 million, versus $166.5 million reported last year.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) 12.4% HIGHER; reported Q4 EPS of ($0.37), $0.23 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $123 million versus the consensus estimate of $131.04 million. Sees FY12 Eylea sales in the US of $250-$300 million.

National Bank of Greece (NYSE: NBG) 12% HIGHER; traders often use this stock as the way to broadly play the action on Greece. With the approval of the latest austerity package, traders are jumping back in this week.

Napco Security Technologies (NASDAQ: NSSC) 9.4% LOWER; reported Q3 EPS of $0.02, versus $0.01 reported last year. Revenue for the quarter came in at $17.62 million, versus $17.61 million reported last year.

Groupon (Nasdaq: GRPN) 9% LOWER; shares down nearly 25 percent since February 9th. Stock pushing below $20 today.




You May Also Be Interested In


Related Categories

Special Reports

Related Entities

Dividend

Add Your Comment